BioSpace News Archive

Business

Biolog-id LLC Partners with LifeServe Blood Center to Implement Cutting-Edge Blood Product Inventory Management Ecosystem

The Technology has the Potential to Become the Standard of Care for Blood Supply Chain Management

January 13, 2020
·
3 min read
Pharm Country

Adaptimmune Announces that SPEAR T-cell Platform Delivers Initial Responses in Four Solid Tumor Indications

Adaptimmune Therapeutics plc reported at the 38th JP Morgan Healthcare Conference, two confirmed Partial Responses – one in a patient with liver cancer and one in a patient with melanoma.

January 13, 2020
·
4 min read
Drug Development

Verona Pharma Reports Positive Top-line Data in 4 Week Phase 2b COPD Study with Nebulized Ensifentrine on Top of Tiotropium Therapy

Primary endpoint met at all doses: ensifentrine produced clinically and statistically significant dose-dependent improvements in lung function

January 13, 2020
·
10 min read
Business

Nanoform Appoints Head of US Sales

Nanoform, an innovative nanoparticle medicine enabling company, has appointed Sally Langa as Head of US Sales.

January 13, 2020
·
3 min read
Business

Exonate Announces Collaboration With Janssen to Develop a New Eye Drop for the Treatment of Retinal Vascular Diseases Including Wet Age-related Macular degeneration (AMD) and Diabetic Macular Oedema (DMO)

The program, facilitated by Johnson & Johnson Innovation, has the potential to improve the treatment of patients with retinal vascular diseases and transform the lives of those suffering from vision loss.

January 13, 2020
·
4 min read
Biotech Beach

HealthLytix Joins Nuance AI Marketplace for Diagnostic Imaging

Summary: HealthLytix’s CT CoPilot software for head CT exams to be available to users of Nuance PowerScribe™, the radiology reporting system trusted by approximately 80 percent of U.S. radiologists across more than 7,000 connected healthcare facilities.

January 13, 2020
·
3 min read
ERS Genomics Licenses CRISPR Gene Editing Technology to Daiichi Sankyo to Support Internal Research and Development

ERS Genomics Limited, which was formed to provide broad access to the foundational CRISPR/Cas9 intellectual property co-owned by Dr. Emmanuelle Charpentier, announced the signing of a license agreement with Daiichi Sankyo, a global pharmaceutical company with corporate origins in Japan.

January 13, 2020
·
1 min read
Drug Development

Neuropore Completes Phase 1 Clinical Trial in Healthy Volunteers with NPT520-34, a Therapeutic Candidate Aimed at Treating Parkinson’s Disease and Amyotrophic Lateral Sclerosis

Neuropore Therapies, Inc. announced that it has successfully completed the Phase 1 clinical trial in healthy volunteers with NPT520-34.

January 13, 2020
·
2 min read
Genetown

bluebird bio Announces Launch in Germany of ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype

First agreements with statutory health insurances utilize bluebird’s innovative value-based payment model and provide coverage for ZYNTEGLO for up to 50% of patients in Germany

January 13, 2020
·
8 min read
Deals

Kyverna Therapeutics Secures $25 Million Series A Funding from Key Investors and Enters into Strategic Collaboration with Gilead Sciences

Collaboration Brings Together Gilead’s Commitment to Advancing Cell Therapy with Kyverna’s Focus on Advanced T Cell Engineering Targeting Autoimmune Diseases

January 13, 2020
·
6 min read